Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro

被引:91
作者
Bredhult, Carolina
Backlin, Britt-Marie
Olovsson, Matts [1 ]
机构
[1] Uppsala Univ, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden
[2] Swedish Museum Nat Hist, Contaminant Res Grp, SE-10405 Stockholm, Sweden
关键词
endocrine disruptors; human endometrial endothelial cells; o; p; '-DDT; PCB; 77; 126; di-n-butyl phthalate; bisphenol A; TCDD;
D O I
10.1016/j.reprotox.2007.03.006
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Endocrine disrupting chemicals (EDCs) pose a potential threat to human reproductive health. We studied the proliferation and viability of human endometrial endothelial cells (HEECs) in vitro after exposure to 2,2-bis(o,p-chlorophenyl)-1,1,1-trichloroethane (op'-DDT), 3,3',4,4'-tetrachlorobiphenyl (CB 77), 3,3',4,4',5-pentachlorobiphenyl (CB 126), di-n-butyl phthalate (DBP), bisphenol A (BPA), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and 17 beta-oestradiol, progesterone, 17 alpha-ethynyl oestradiol and levonorgestrel. Cell proliferation was studied using immunocytochemistry for PCNA expression and a 5-bromo-2'-deoxyuridine assay. Cell viability was studied by vital staining with propidium iodide and Hoechst 33258. HEECs in primary culture responded with increased proliferation to oestradiol and with decreased proliferation to levonorgestrel and the EDCs. Some EDCs also affected cell viability and increased the proportion of necrotic cells. However, the decrease in proliferation in response to DBP and TCDD cannot be explained by cell death. In light of these results, it is possible that the EDCs could have effects in vivo as well as in vitro, and influence processes involving for example endometrial angiogenesis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:550 / 559
页数:10
相关论文
共 64 条
[1]  
[Anonymous], ENV HLTH PERSPECT
[2]   Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives [J].
Baisini, O ;
Benini, F ;
Petraglia, F ;
Kuhnz, W ;
Scalia, S ;
Marschall, HU ;
Brunetti, G ;
Tauschel, HD ;
Lanzini, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (07) :481-487
[3]   BINDING OF POLYCHLORINATED-BIPHENYLS CLASSIFIED AS EITHER PHENOBARBITONE-TYPE, 3-METHYLCHOLANTHRENE-TYPE OR MIXED-TYPE INDUCERS TO CYTOSOLIC AH RECEPTOR [J].
BANDIERA, S ;
SAFE, S ;
OKEY, AB .
CHEMICO-BIOLOGICAL INTERACTIONS, 1982, 39 (03) :259-277
[4]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[5]  
BIGNERT A, 2000, COMMENTS NATL SWEDIS
[6]  
BITMAN J, 1968, Science (Washington D C), V162, P371, DOI 10.1126/science.162.3851.371
[7]   ESTROGENICITY OF O,P'-DDT IN RATS [J].
CECIL, HC ;
BITMAN, J ;
HARRIS, SJ .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1971, 19 (01) :61-&
[8]   In utero and lactational exposure of female Holtzman rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Modulation of the estrogen signal [J].
Chaffin, CL ;
Peterson, RE ;
Hutz, RJ .
BIOLOGY OF REPRODUCTION, 1996, 55 (01) :62-67
[9]   Epidemiologic studies of PCB congener profiles in north American fish consuming populations [J].
Chiu, A ;
Beaubier, J ;
Chiu, J ;
Chan, L ;
Gerstenberger, S .
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS, 2004, 22 (01) :13-36
[10]   Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium [J].
Critchley, HOD ;
Brenner, RM ;
Henderson, TA ;
Williams, K ;
Nayak, NR ;
Slayden, OD ;
Millar, MR ;
Saunders, PTK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1370-1378